For over 45 years, ABEC has exclusively focused on providing customized process solutions and services for the development and manufacturing of the entire range of biopharmaceutical products, including vaccines, antibodies, recombinant proteins, and gene therapy. Privately held and entrepreneurial since inception, our responsiveness and flexibility are essential to our customers’ success, and therefore inherently built into our DNA. With our complete in-house capabilities and industry-leading capacity, no other provider in the industry can match ABEC’s speed in delivering process solutions for COVID-19 biotherapeutics.
ABEC is already supporting multiple industry leaders in their efforts to advance COVID-19 vaccines and therapeutic antibodies. These companies are utilizing ABEC’s full range of customized capabilities, including site services, single-use systems, and stainless steel equipment. ABEC is able to do more, and can: